α-Methyltryptamine

α-Methyltryptamine
Clinical data
Other names	Indopan; α-Methyl-3-indoleethanamine; 3-(2-Aminopropyl)indole; IT-290, IT-403, U-14,164E, 3-IT
Routes of; administration	Oral, Insufflation, Rectal, Smoked, IM, IV
ATC code	none;
Legal status
Legal status	AU: S8 (Controlled drug); BR: Class F2 (Prohibited psychotropics); CA: Unscheduled; DE: Anlage I (Authorized scientific use only); UK: Class A; US: Schedule I;
Identifiers
	IUPAC name 1-(1H-Indol-3-yl)propan-2-amine;
CAS Number	299-26-3 ;
PubChem CID	9287;
DrugBank	DB01446 ;
ChemSpider	8930 ;
UNII	BIK35ACJ0Q;
KEGG	C20127;
ChEBI	CHEBI:59020 ;
ChEMBL	ChEMBL30713 ;
ECHA InfoCard	100.005.522
Chemical and physical data
Formula	C11H14N2
Molar mass	174.247 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES NC(CC1=CNC2=C1C=CC=C2)C;
	InChI InChI=1S/C11H14N2/c1-8(12)6-9-7-13-11-5-3-2-4-10(9)11/h2-5,7-8,13H,6,12H2,1H3 ; Key:QSQQQURBVYWZKJ-UHFFFAOYSA-N ;
	(verify)

α-Methyltryptamine (abbreviated as αMT, AMT) is a psychedelic, stimulant, and entactogen drug of the tryptamine class. It was originally developed as an antidepressant by chemists at Upjohn in the 1960s, and was used briefly as an antidepressant in Russia under the trade name Indopan before being discontinued.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.